Related Experiment Video
Updated: Jun 23, 2025

11:37
QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii
Published on: June 22, 2017
16.3K
Fine mapping a QTL for BYDV-PAV resistance in maize
Maria Schmidt1, Ricardo Guerreiro1, Nadia Baig1
1Institute for Quantitative Genetics and Genomics of Plants, Heinrich Heine University, Düsseldorf, Germany.
Summary
Barley yellow dwarf virus (BYDV)-PAV resistance in maize is linked to two genes, Zm00001eb428010 and Zm00001eb428020. A specific deletion in Zm00001eb428010 confers resistance by altering protein properties.
Area of Science:
- Plant Pathology
- Genetics
- Molecular Biology
Background:
- Barley yellow dwarf (BYD) is a significant cereal virus disease causing substantial yield losses globally.
- Developing genetically resistant cultivars is crucial for economical and eco-friendly BYD control.
Purpose of the Study:
- Identify the gene responsible for BYDV-PAV resistance in maize.
- Investigate genetic variations influencing maize susceptibility to BYDV-PAV.
- Analyze BYDV-PAV infection's impact on gene expression in maize inbreds with varying resistance levels.
Main Methods:
- Utilized two biparental mapping populations to narrow down the quantitative trait locus (QTL) for BYDV-PAV resistance.
- Employed association mapping and gene expression analysis to pinpoint candidate resistance genes.
- Sequenced candidate genes to identify single nucleotide polymorphisms (SNPs) and structural variations.
Main Results:
- Reduced the BYDV-PAV resistance QTL to a 0.3 Mbp region containing nine genes.
- Identified Zm00001eb428010 and Zm00001eb428020 as key candidate genes for BYDV-PAV resistance.
- Found a 54 bp deletion in the 5'-UTR and a protein-altering variant in Zm00001eb428010 in resistant maize inbreds.
Conclusions:
- Zm00001eb428010 and Zm00001eb428020 are strongly implicated in conferring BYDV-PAV resistance.
- Altered protein abundance or properties due to variations in Zm00001eb428010 likely mediate resistance.
- These genes may confer resistance by interfering with virus replication or inducing ROS signaling pathways.

